UPSI Digital Repository (UDRep)
|
|
|
Abstract : Universiti Pendidikan Sultan Idris |
Background: Meyerozyma guilliermondii is a prospective yeast that has extensively contributed to the biotechnology sector. In 2015, M. guilliermondii strain SO which was isolated from spoiled orange has successfully been developed as an inducer-free expression system and attained a significant impact in producing industrially important recombinant proteins. The species possesses high similarity to Candida albicans which may cause candidiasis. The industrial-benefiting M. guilliermondii strain SO has been underexplored for its virulence status. Thus, this study aimed to document the potential virulence factors through the comprehensive in silico analysis of M. guilliermondii strain SO genome. This analysis demonstrated the molecular characterization which could distinguish the pathogenicity status of M. guilliermondii. Results: The genome data were generated from Illumina HiSeq 4000 sequencing platform and assembled into 51 scaffolds successfully accumulating a genome size of 10.63 Mbp. These enclosed 5,335 CDS genes and 5,349 protein sequences with 43.72% GC content. About 99.29% of them were annotated to public databases. Komagataella phaffii, Saccharomyces cerevisiae and the reference strain of M. guilliermondii (ATCC 6260) were used as the controls. They were compared with our in-house strain SO to identify the consensus domain or subdomain which could putatively be considered as virulence factors. Candida albicans was used as the pathogenic model. Hence, hidden Markov model against strain SO proteome had identified secreted aspartic proteases (SAP), phospholipase C (PLC) and phospholipase D (PLD) with an E-value of 2.4e?107, 9.5e?200 and 0.0e+00, respectively, in resemblance of C. albicans. The topology of the phylogenetic analysis indicated that these virulence factors in M. guilliermondii strain SO and C. albicans branched from the same node and clustered together as a clade, signifying their molecular relatedness and congeneric among these species, subsequently proposing the virulence status of M. guilliermondii. Conclusion: The SAP, PLC and PLD genes features that were significant in expressing determinants of pathogenicity were successfully identified in M. guilliermondii strain SO genome dataset, thus concluding the virulency of this species. On account of this finding, the strategy of gene knockout through CRISPR-Cas9 or homologous recombination strategies is needed to engineer the feasible novel expression host system. Over and above, the genetically modified strain of M. guilliermondii allegedly may eradicate the risk of candidiasis infection. 2023, The Author(s). |
References |
Locey KJ, Lennon JT (2016) Scaling laws predict global microbial diversity. Proc Natl Acad Sci 113(21):5970–5975 Hawksworth DL, Lücking R (2017) Fungal diversity revisited: 2.2 to 3.8 million species. Microbiology Spectrum. 5(4):4–5 de Hoog GS, Ahmed SA, Danesi P, Guillot J, Gräser Y (2018) Distribution of pathogens and outbreak fungi in the fungal kingdom. In: Seyedmousavi S, de Hoog GS, Guillot J, Verweij P (eds) Emerging and epizootic fungal infections in animals. Springer, Dordrecht, pp 3–16 Hyde KD, Abdullah MSA, Andersen B, Boekhout T, Buzina W, Dawson TL Jr, Eastwood DC, Jones EBG, de Hoog S, Kang Y, Longcore JE, Richard-Forget F, Stadler M, Theelen B, Thongbai B, Tsui CKM (2018) The world’s ten most feared fungi. Fungal Diversity 93:161–194 Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A (2022) Prevalence of biofilms in Candida spp bloodstream infections: a metaanalysis. PLoS ONE 17(2):e0263522 Lopes JP, Lionakis MS (2022) Pathogenesis and virulence of Candida albicans. Virulence 13(1):89–121 Bates S (2008) Pathogenic fungi: insights in molecular biology. Expert Rev Anti Infect Ther 6(5):591–592 Kainz K, Bauer MA, Madeo F, Carmona-Gutierrez D (2020) Fungal infections in humans: the silent crisis. Microbial Cell 7(6):143–145 Xiao Z, Wang Q, Zhu F, An Y (2019) Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control 8:89 Cavalheiro M, Teixeira MC (2018) Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne) 5:28 Lo HJ, Kohler JR, DiDomenico B, Loebenberg L, Cacciapuoti A, Fink GR (1997) Nonfilamentous C albicans mutants are avirulent. Cell 90:939–949 Nunes CS, Kumar V (2018) Enzymes in human and animal nutrition: principles and perspectives. Academic Press 267–277 Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9(7):327–335 Kurtzman CP, Meyerozyma Kurtzman & M, Suzuki (2010) In Kurtzman CP, Fell JW, Boekhout T, eds. The yeast. 5th ed. London, Elsevier; 2011; p 621–624. Dujon B (2010) Yeast evolutionary genomics. Nat Rev Genet 11(7):512–524 Santos MA, Gomes AC, Santos MC, Carreto LC, Moura GR (2011) The genetic code of the fungal CTG clade. CR Biol 334(8):607–611 Sibirny AA, Boretsky YR (2009) Pichia guilliermondii. In: Satyanarayana T, Kunze G (eds) Yeast biotechnology: diversity and applications. Springer, Dordrecht, pp 113–134 Oslan SN, Salleh AB, Rahman RNZRA, Basri M, Chor ALT (2012) Locally isolated yeasts from Malaysia: identification phylogenetic study and characterization. Acta Biochim Pol 59(2):225–229 Oslan SN, Salleh AB, Rahman RNZRA, Leow TC, Sukamat H, Basri M (2015) A newly isolated yeast as an expression host for recombinant lipase. Cell Molecul Biol Lett 20(2):279–293 Valli M, Tatto NE, Peymann A, Gruber C, Landes N, Ekker H, Thallinger GG, Mattanovich D, Gasser B, Graf AB (2016) Curation of the genome annotation of Pichia pastoris (Komagataella phaffii) CBS7435 from gene level to protein function. FEMS Yeast Res 16(6):fow051 Mahyon NI (2017) Structural investigation of alcohol oxidase from Meyerozyma guilliermondii and the use of its promoter for recombinant protein expression. Master’s thesis. Universiti Putra Malaysia Nasir NSM, Leow CT, Oslan SNH, Salleh AB, Oslan SN (2020) Molecular expression of a recombinant thermostable bacterial amylase from Geobacillus stearothermophilus SR74 using methanol-free Meyerozyma guilliermondii strain SO yeast system. BioResources 15(2):3161–3172 Castillo-Bejarano JI, Tamez-Rivera O, Mirabal-García M, Luengas-Bautista M, Montes-Figueroa AG, Fortes-Gutiérrez S, González-Saldaña N (2020) Invasive candidiasis due to Candida guilliermondii complex: epidemiology and antifungal susceptibility testing from a third-level pediatric center in Mexico. J Pediatric Infectious Diseases Soc 9(3):404–406 Deorukhkar SC, Saini S, Mathew S (2014) Non-albicans Candida infection: an emerging threat. Interdisciplinary perspectives on infectious diseases Girmenia C, Pizzarelli G, Cristini F, Barchiesi F, Spreghini E, Scalise G, Martino P (2006) Candida guilliermondii fungemia in patients with hematologic malignancies. J Clin Microbiol 44(7):2458–2464 Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA (2010) Results from the ARTEMIS DISK global antifungal surveillance study 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole determined by CLSI standardized disk diffusion. J Clinic Microbiol 48(4):1366–1377 Tseng TY, Chen TC, Ho CM, Lin PC, Chou CH, Tsai CT, Wang JH, Chi CY, Ho MW (2017) Clinical features, antifungal susceptibility and outcome of Candida guilliermondii fungemia: an experience in a tertiary hospital in mid-Taiwan. J Microbiol Immunol Infect 51:552–558 Fitzpatrick DA, Logue ME, Stajich JE, Butler G (2006) A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC Evol Biol 6:99 |
This material may be protected under Copyright Act which governs the making of photocopies or reproductions of copyrighted materials. You may use the digitized material for private study, scholarship, or research. |